#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal squamous cell carcinoma Acute on chronic liver failure CDKL5 deficiency disorder Ischaemic stroke Progressive multifocal leukoencephalopathy Hereditary angioedema Neuroendocrine carcinoma Encephalopathy neonatal Chronic graft versus host disease Myelodysplastic syndrome with excess blasts Carcinoid syndrome Squamous cell carcinoma of head and neck Alveolar proteinosis Usher's syndrome Glioblastoma multiforme More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Basic Information Nephrotic syndrome – Trials in Disease Glycogen storage disease type I – Trials in Disease Retinitis pigmentosa – Basic Information Urea cycle disorder – Trials in Disease Lennox-Gastaut syndrome – Treatment Haemolytic uraemic syndrome – Basic Information Netherton’s syndrome – Treatment Rhabdomyosarcoma – Diagnostics Krabbe’s disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triptorelin Acetate Colesevelam Vib1116 Vh4524184 Sodium Cromoglicate Fitusiran Netupitant MAGNESIUM ACETATE TETRAHYDRATE Alfacalcidol Peposertib MOLNUPIRAVIR Baricitinib Azithromycin Dihydrate SOFOSBUVIR Human Fibrinogen Narsoplimab Tipiracil Hydrochloride Ertugliflozin Dalteparin Sodium Fenofibrate More therapies…

    Learn about Your Condition

    Colitis ulcerative Decreased appetite Osteosarcoma metastatic Hepatoblastoma Hairy cell leukaemia recurrent Multifocal motor neuropathy Netherton's syndrome Spinal osteoarthritis Senile dementia Ocular hypertension Mumps Peripheral ischaemia Biliary tract disorder Head and neck cancer stage IV Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cholangiocarcinoma

  • Study on Hilar Cholangiocarcinoma Treatment Using Porfimer Sodium and Foscan for Patients with Bile Duct Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Germany

  • Study on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ivosidenib
    Austria Belgium France Germany Ireland Italy +4

  • Study of Ivosidenib, Durvalumab, and Gemcitabine/Cisplatin for Patients with Advanced Cholangiocarcinoma with IDH1 Mutation

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Ivosidenib
    • Cisplatin
    • Durvalumab
    France Germany Spain

  • Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Pancreatic carcinoma
    • Gastric cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany

  • Study of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Ivosidenib
    Austria Germany The Netherlands Sweden

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    • Cervix carcinoma recurrent
    • Endometrial adenocarcinoma
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9
Previous Page
1 2 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!